Dual SGLT1 and SGLT2 inhibitor sotagliflozin achieves FDA approval: landmark or landmine?
Milton Packer
Topics & Concepts
Food and drug administrationClinical trialMedicineLandmarkDual (grammatical number)Drug approvalDrugInternal medicinePharmacologyComputer scienceArtificial intelligenceLiteratureArtDiabetes Treatment and ManagementPharmacology and Obesity TreatmentDiabetes Management and Research